Jun. 6, 2017
"We are very excited to combine Verios with our existing business," said Diego Lopez Casanello, President, Arysta LifeScience. "With this step, we add an innovative microbial technology platform to our biosolutions business that has growth potential both within South Africa as well as in other regions of the world."
"Arysta LifeScience is committed to strengthening its leadership in biosolutions around the world," Casanello added. "We will continue to evaluate opportunities in this exciting, high-growth market as a key pillar of our strategy."
"We are looking forward to joining Arysta LifeScience and continuing to execute our vision," said Daniel Marais, General Manager, Verios. "We believe our two businesses are highly complementary, and we are excited about the potential of our combined offering."